BAL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/09/2024 inter alia to consider and approve 1. Allotment of equity shares to the employees of the Company upon conversion of stock options vested on them. 2. To consider expanding its manufacturing presence to meet growing demand for APIs. 3.Any other matters incidental to the business operations and ensuing AGM of the Company.